This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Abt MC, McKenney PT, Pamer EG.Clostridium difficile colitis: pathogenesis and host defence. Nat Rev Microbiol. 2016 Oct; 14(10): 609–620. https://doi.org/10.1038/nrmicro.2016.108AbtMCMcKenneyPTPamerEGClostridium difficile colitis: pathogenesis and host defenceNat Rev Microbiol2016Oct1410609620https://doi.org/10.1038/nrmicro.2016.10810.1038/nrmicro.2016.108510905427573580Search in Google Scholar
Allegretti JR, Kearney S, Li N, Bogart E, Bullock K, Gerber GK, Bry L, Clish CB, Alm E, Korzenik JR. Recurrent Clostridium difficile infection associates with distinct bile acid and microbiome profiles. Aliment Pharmacol Ther. 2016 Jun;43(11):1142–1153. https://doi.org/10.1111/apt.13616AllegrettiJRKearneySLiNBogartEBullockKGerberGKBryLClishCBAlmEKorzenikJRRecurrent Clostridium difficile infection associates with distinct bile acid and microbiome profilesAliment Pharmacol Ther2016Jun431111421153https://doi.org/10.1111/apt.1361610.1111/apt.13616521457327086647Search in Google Scholar
Babaknejad N, Nayeri H, Hemmati R, Bahrami S, Esmaillzadeh A. An overview of FGF19 and FGF21: the therapeutic role in the treatment of the metabolic disorders and obesity FGF19. Horm Metab Res. 2018 Jun;50(6):441–452. https://doi.org/10.1055/a-0623-2909BabaknejadNNayeriHHemmatiRBahramiSEsmaillzadehAAn overview of FGF19 and FGF21: the therapeutic role in the treatment of the metabolic disorders and obesity FGF19Horm Metab Res2018Jun506441452https://doi.org/10.1055/a-0623-290910.1055/a-0623-290929883971Search in Google Scholar
Bidault-Jourdainne V, Merlen G, Glénisson M, Doignon I, Garcin I, Péan N, Boisgard R, Ursic-Bedoya J, Serino M, Ullmer C, et al. TGR5 controls bile acid composition and gallbladder function to protect the liver from bile acid overload. JHEP Reports. 2021 Nov; 3(2):100214. https://doi.org/10.1016/j.jhepr.2020.100214Bidault-JourdainneVMerlenGGlénissonMDoignonIGarcinIPéanNBoisgardRUrsic-BedoyaJSerinoMUllmerCTGR5 controls bile acid composition and gallbladder function to protect the liver from bile acid overloadJHEP Reports2021Nov32100214https://doi.org/10.1016/j.jhepr.2020.10021410.1016/j.jhepr.2020.100214787298233604531Search in Google Scholar
Britton RA, Young VB. Role of the intestinal microbiota in resistance to colonization by Clostridium difficile. Gastroenterology. 2014 May; 146(6):1547–1553. https://doi.org/10.1053/j.gastro.2014.01.059BrittonRAYoungVBRole of the intestinal microbiota in resistance to colonization by Clostridium difficileGastroenterology2014May146615471553https://doi.org/10.1053/j.gastro.2014.01.05910.1053/j.gastro.2014.01.059399585724503131Search in Google Scholar
Buffie CG, Bucci V, Stein RR, McKenney PT, Ling L, Gobourne A, No D, Liu H, Kinnebrew M, Viale A, et al. Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nature. 2015 Jan;517:205–208. https://doi.org/10.1038/nature13828BuffieCGBucciVSteinRRMcKenneyPTLingLGobourneANoDLiuHKinnebrewMVialeAPrecision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficileNature2015Jan517205208https://doi.org/10.1038/nature1382810.1038/nature13828435489125337874Search in Google Scholar
Cabrera D, Arab JP, Arrese M. UDCA, NorUDCA, and TUDCA in liver diseases: a review of their mechanisms of action and clinical applications. In: Fiorucci S, Distrutti E, editors. Bile acids and their receptors. Handbook of experimental pharmacology. Cham (Switzerland): Springer; 2019(256). p. 237–264. https://doi.org/10.1007/164_2019_241CabreraDArabJPArreseMUDCA, NorUDCA, and TUDCA in liver diseases: a review of their mechanisms of action and clinical applications. In: Fiorucci S, Distrutti E, editors. Bile acids and their receptorsHandbook of experimental pharmacologyCham (Switzerland)Springer2019(256).237264https://doi.org/10.1007/164_2019_24110.1007/164_2019_24131236688Search in Google Scholar
Chiang JYL, Ferrell JM. Bile acids as metabolic regulators and nutrient sensors. Annu Rev Nutr. 2019 Aug;39:175–200. https://doi.org/10.1146/annurev-nutr-082018-124344ChiangJYLFerrellJMBile acids as metabolic regulators and nutrient sensorsAnnu Rev Nutr2019Aug39175200https://doi.org/10.1146/annurev-nutr-082018-12434410.1146/annurev-nutr-082018-124344699608931018107Search in Google Scholar
Czepiel J, Dróżdż M, Pituch H, Kuijper EJ, Perucki W, Mielimonka A, Goldman S, Wultańska D, Garlicki A, Biesiada G.Clostridium difficile infection: review. Eur J Clin Microbiol Infect Dis. 2019 Jul;38(7):1211–1221. https://doi.org/10.1007/s10096-019-03539-6CzepielJDróżdżMPituchHKuijperEJPeruckiWMielimonkaAGoldmanSWultańskaDGarlickiABiesiadaGClostridium difficile infection: reviewEur J Clin Microbiol Infect Dis2019Jul38712111221https://doi.org/10.1007/s10096-019-03539-610.1007/s10096-019-03539-6657066530945014Search in Google Scholar
Dawson PA, Karpen SJ. Intestinal transport and metabolism of bile acids. J Lipid Res. 2015 Jun;56(6):1085–1099. https://doi.org/10.1194/jlr.R054114DawsonPAKarpenSJIntestinal transport and metabolism of bile acidsJ Lipid Res2015Jun56610851099https://doi.org/10.1194/jlr.R05411410.1194/jlr.R054114444286725210150Search in Google Scholar
Di Gregorio MC, Cautela J, Galantini L. Physiology and physical chemistry of bile acids. Int J Mol Sci. 2021 Feb;22(4):1780. https://doi.org/10.3390/ijms22041780Di GregorioMCCautelaJGalantiniLPhysiology and physical chemistry of bile acidsInt J Mol Sci2021Feb2241780https://doi.org/10.3390/ijms2204178010.3390/ijms22041780791680933579036Search in Google Scholar
Duboc H, Taché Y, Hofmann AF. The bile acid TGR5 membrane receptor: from basic research to clinical application. Dig Liver Dis. 2014 Apr;46(4):302–312. https://doi.org/10.1016/j.dld.2013.10.021DubocHTachéYHofmannAFThe bile acid TGR5 membrane receptor: from basic research to clinical applicationDig Liver Dis2014Apr464302312https://doi.org/10.1016/j.dld.2013.10.02110.1016/j.dld.2013.10.021595319024411485Search in Google Scholar
Ferrebee CB, Dawson PA. Metabolic effects of intestinal absorption and enterohepatic cycling of bile acids. Acta Pharm Sin B. 2015 Mar;5(2):129–134. https://doi.org/10.1016/j.apsb.2015.01.001FerrebeeCBDawsonPAMetabolic effects of intestinal absorption and enterohepatic cycling of bile acidsActa Pharm Sin B2015Mar52129134https://doi.org/10.1016/j.apsb.2015.01.00110.1016/j.apsb.2015.01.001462921426579438Search in Google Scholar
Fiorucci S, Di Giorgio C, Distrutti E. Obeticholic acid: an update of its pharmacological activities in liver disorders. In: Fiorucci S, Distrutti E, editors. Bile acids and their receptors. Handbook of experimental pharmacology. Cham (Switzerland): Springer; 2019 (256). p. 283–295. https://doi.org/10.1007/164_2019_227FiorucciSDi GiorgioCDistruttiEObeticholic acid: an update of its pharmacological activities in liver disordersIn:FiorucciSDistruttiEeditors.Bile acids and their receptorsHandbook of experimental pharmacologyCham (Switzerland)Springer2019(256).283295https://doi.org/10.1007/164_2019_22710.1007/164_2019_22731201552Search in Google Scholar
Fiorucci S, Distrutti E. The pharmacology of bile acids and their receptors. In: Fiorucci S, Distrutti E, editors. Bile acids and their receptors. Handbook of experimental pharmacology. Cham (Switzerland): Springer; 2019(256). p. 3–18. https://doi.org/10.1007/164_2019_238FiorucciSDistruttiEThe pharmacology of bile acids and their receptorsIn:FiorucciSDistruttiEeditors.Bile acids and their receptorsHandbook of experimental pharmacologyCham (Switzerland)Springer2019(256).318https://doi.org/10.1007/164_2019_23810.1007/164_2019_23831201555Search in Google Scholar
Floreani A. Experimental pharmacological agents for the treatment of primary biliary cholangitis. J Exp Pharmacol. 2020 Dec;12: 643–652. https://doi.org/10.2147/JEP.S267375FloreaniAExperimental pharmacological agents for the treatment of primary biliary cholangitisJ Exp Pharmacol2020Dec12643652https://doi.org/10.2147/JEP.S26737510.2147/JEP.S267375775171233364858Search in Google Scholar
Foley MH, O’Flaherty S, Barrangou R, Theriot CM. Bile salt hydrolases: gatekeepers of bile acid metabolism and host-microbiome crosstalk in the gastrointestinal tract. PLoS Pathog. 2019 Mar;15(3):e1007581. https://doi.org/10.1371/journal.ppat.1007581FoleyMHO’FlahertySBarrangouRTheriotCMBile salt hydrolases: gatekeepers of bile acid metabolism and host-microbiome crosstalk in the gastrointestinal tractPLoS Pathog2019Mar153e1007581https://doi.org/10.1371/journal.ppat.100758110.1371/journal.ppat.1007581640504630845232Search in Google Scholar
Gonzalez FJ, Jiang C, Bisson WH, Patterson AD. Inhibition of farnesoid X receptor signaling shows beneficial effects in human obesity. J Hepatol. 2015 Jun;62(6):1234–1236. https://doi.org/10.1016/j.jhep.2015.02.043GonzalezFJJiangCBissonWHPattersonADInhibition of farnesoid X receptor signaling shows beneficial effects in human obesityJ Hepatol2015Jun62612341236https://doi.org/10.1016/j.jhep.2015.02.04310.1016/j.jhep.2015.02.043634626725747705Search in Google Scholar
Guh AY, Mu Y, Winston LG, Johnston H, Olson D, Farley MM, Wilson LE, Holzbauer SM, Phipps EC, Dumyati GK, et al. Trends in U.S. Burden of Clostridioides difficile infection and outcomes. N Eng J Med. 2020 Apr;382(14):1320–1330. https://doi.org/10.1056/NEJMoa1910215GuhAYMuYWinstonLGJohnstonHOlsonDFarleyMMWilsonLEHolzbauerSMPhippsECDumyatiGKTrends in U.S. Burden of Clostridioides difficile infection and outcomesN Eng J Med2020Apr3821413201330https://doi.org/10.1056/NEJMoa191021510.1056/NEJMoa1910215786188232242357Search in Google Scholar
Hashimoto S, Igimi H, Uchida K, Satoh T, Benno Y, Takeuchi N. Effects of β-lactam antibiotics on intestinal microflora and bile acid metabolism in rats. Lipids. 1996 Jun;31(6):601–609. https://doi.org/10.1007/BF02523830HashimotoSIgimiHUchidaKSatohTBennoYTakeuchiNEffects of β-lactam antibiotics on intestinal microflora and bile acid metabolism in ratsLipids1996Jun316601609https://doi.org/10.1007/BF0252383010.1007/BF025238308784740Search in Google Scholar
Jose S, Mukherjee A, Horrigan O, Setchell KDR, Zhang W, Moreno-Fernandez ME, Andersen H, Sharma D, Haslam DB, Divanovic S, et al. Obeticholic acid ameliorates severity of Clostri dioides difficile infection in high fat diet-induced obese mice. Mucosal Immunol. 2021 Mar;14(2):500–510. https://doi.org/10.1038/s41385-020-00338-7JoseSMukherjeeAHorriganOSetchellKDRZhangWMoreno-FernandezMEAndersenHSharmaDHaslamDBDivanovicSObeticholic acid ameliorates severity of Clostri dioides difficile infection in high fat diet-induced obese miceMucosal Immunol2021Mar142500510https://doi.org/10.1038/s41385-020-00338-710.1038/s41385-020-00338-7788974732811993Search in Google Scholar
Kang JD, Myers CJ, Harris SC, Kakiyama G, Lee IK, Yun BS, Matsuzaki K, Furukawa M, Min HK, Bajaj JS, et al. Bile acid 7α-dehydroxylating gut gacteria secrete antibiotics that inhibit Clostridium difficile : role of secondary bile acids. Cell Chem Biol. 2019 Jan; 26(1):27–34.e4. https://doi.org/10.1016/j.chembiol.2018.10.003KangJDMyersCJHarrisSCKakiyamaGLeeIKYunBSMatsuzakiKFurukawaMMinHKBajajJSBile acid 7α-dehydroxylating gut gacteria secrete antibiotics that inhibit Clostridium difficile : role of secondary bile acidsCell Chem Biol2019Jan2612734.e4https://doi.org/10.1016/j.chembiol.2018.10.00310.1016/j.chembiol.2018.10.003633851430482679Search in Google Scholar
Keith JW, Dong Q, Sorbara MT, Becattini S, Sia JK, Gjonbalaj M, Seok R, Leiner IM, Littmann ER, Pamer EG. Impact of antibiotic-resistant bacteria on immune activation and Clostridioides difficile infection in the mouse intestine. Infect Immun. 2020;88(4):e00362-19. https://doi.org/10.1128/IAI.00362-19KeithJWDongQSorbaraMTBecattiniSSiaJKGjonbalajMSeokRLeinerIMLittmannERPamerEGImpact of antibiotic-resistant bacteria on immune activation and Clostridioides difficile infection in the mouse intestineInfect Immun2020884e00362-19https://doi.org/10.1128/IAI.00362-1910.1128/IAI.00362-19709314431907198Search in Google Scholar
Kim DJ, Yoon S, Ji SC, Yang J, Kim YK, Lee S, Yu KS, Jang IJ, Chung JY, Cho JY. Ursodeoxycholic acid improves liver function via phenylalanine/tyrosine pathway and microbiome remodelling in patients with liver dysfunction. Sci Rep. 2018 Aug;8(1):11874. https://doi.org/10.1038/s41598-018-30349-1KimDJYoonSJiSCYangJKimYKLeeSYuKSJangIJChungJYChoJYUrsodeoxycholic acid improves liver function via phenylalanine/tyrosine pathway and microbiome remodelling in patients with liver dysfunctionSci Rep2018Aug8111874https://doi.org/10.1038/s41598-018-30349-110.1038/s41598-018-30349-1608287930089798Search in Google Scholar
Liu J, Lu H, Lu YF, Lei X, Cui JY, Ellis E, Strom SC, Klaassen CD. Potency of individual bile acids to regulate bile acid synthesis and transport genes in primary human hepatocyte cultures. Toxicol Sci. 2014 Oct;141(2):538–546. https://doi.org/10.1093/toxsci/kfu151LiuJLuHLuYFLeiXCuiJYEllisEStromSCKlaassenCDPotency of individual bile acids to regulate bile acid synthesis and transport genes in primary human hepatocyte culturesToxicol Sci2014Oct1412538546https://doi.org/10.1093/toxsci/kfu15110.1093/toxsci/kfu151427105025055961Search in Google Scholar
Mahida YR. New concepts in C. difficile management. Br Med Bull. 2019 Sep;131(1):109–118. https://doi.org/10.1093/bmb/ldz029MahidaYRNew concepts in C. difficile managementBr Med Bull2019Sep1311109118https://doi.org/10.1093/bmb/ldz02910.1093/bmb/ldz02931583398Search in Google Scholar
Marin JJG, Macias RIR, Briz O, Banales JM, Monte MJ. Bile acids in physiology, pathology and pharmacology. Curr Drug Metab. 2015; 17(1):4–29. https://doi.org/10.2174/1389200216666151103115454MarinJJGMaciasRIRBrizOBanalesJMMonteMJBile acids in physiology, pathology and pharmacologyCurr Drug Metab2015171429https://doi.org/10.2174/138920021666615110311545410.2174/138920021666615110311545426526836Search in Google Scholar
Matsubara T, Li F, Gonzalez FJ. FXR signaling in the enterohepatic system. Mol Cell Endocrinol. 2013 Apr;368(1–2):17–29. https://doi.org/10.1016/j.mce.2012.05.004MatsubaraTLiFGonzalezFJFXR signaling in the enterohepatic systemMol Cell Endocrinol2013Apr3681–21729https://doi.org/10.1016/j.mce.2012.05.00410.1016/j.mce.2012.05.004349114722609541Search in Google Scholar
McDonald LC, Gerding DN, Johnson S, Bakken JS, Carroll KC, Coffin SE, Dubberke ER, Garey KW, Gould CV, Kelly C, et al. Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis. 2018 Mar;66(7):e1–e48. https://doi.org/10.1093/cid/cix1085McDonaldLCGerdingDNJohnsonSBakkenJSCarrollKCCoffinSEDubberkeERGareyKWGouldCVKellyCClinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)Clin Infect Dis2018Mar667e1e48https://doi.org/10.1093/cid/cix108510.1093/cid/cix1085601898329462280Search in Google Scholar
Mohandas S, Vairappan B. Role of pregnane X-receptor in regulating bacterial translocation in chronic liver diseases. World J Hepatol. 2017 Nov;9(32):1210–1226. https://doi.org/10.4254/wjh.v9.i32.1210MohandasSVairappanBRole of pregnane X-receptor in regulating bacterial translocation in chronic liver diseasesWorld J Hepatol2017Nov93212101226https://doi.org/10.4254/wjh.v9.i32.121010.4254/wjh.v9.i32.1210569660429184608Search in Google Scholar
Mulki R, Baumann AJ, Alnabelsi T, Sandhu N, Alhamshari Y, Wheeler DS, Perloff S, Katz PO. Body mass index greater than 35 is associated with severe Clostridium difficile infection. Aliment Pharmacol Ther. 2017 Jan;45(1):75–81. https://doi.org/10.1111/apt.13832MulkiRBaumannAJAlnabelsiTSandhuNAlhamshariYWheelerDSPerloffSKatzPOBody mass index greater than 35 is associated with severe Clostridium difficile infectionAliment Pharmacol Ther2017Jan4517581https://doi.org/10.1111/apt.1383210.1111/apt.1383227790736Search in Google Scholar
Mullish BH, Allegretti JR. The contribution of bile acid metabolism to the pathogenesis of Clostridioides difficile infection. Therap Adv Gastroenterol. 2021 May;14:17562848211017724. https://doi.org/10.1177/17562848211017725MullishBHAllegrettiJRThe contribution of bile acid metabolism to the pathogenesis of Clostridioides difficile infectionTherap Adv Gastroenterol2021May1417562848211017724. https://doi.org/10.1177/1756284821101772510.1177/17562848211017725816581534104212Search in Google Scholar
Napolitano LM, Edmiston CE.Clostridium difficile disease: diagnosis, pathogenesis, and treatment update. Surgery. 2017 Aug; 162(2): 325–348. https://doi.org/10.1016/j.surg.2017.01.018NapolitanoLMEdmistonCEClostridium difficile disease: diagnosis, pathogenesis, and treatment updateSurgery2017Aug1622325348https://doi.org/10.1016/j.surg.2017.01.01810.1016/j.surg.2017.01.01828267992Search in Google Scholar
Novotny K, Hapshy V, Nguyen H, Parmar M. Obeticholic Acid. [Internet]. Treasure Island (USA): StatPearls Publishing; 2021 [cited 2021 Oct 11]. Available from https://www.ncbi.nlm.nih.gov/books/NBK567735/NovotnyKHapshyVNguyenHParmarMObeticholic Acid. [Internet]Treasure Island (USA)StatPearls Publishing2021[cited 2021 Oct 11]. Available from https://www.ncbi.nlm.nih.gov/books/NBK567735/Search in Google Scholar
Palmieri LJ, Rainteau D, Sokol H, Beaugerie L, Dior M, Coffin B, Humbert L, Eguether T, Bado A, Hoys S, et al. Inhibitory effect of ursodeoxycholic acid on Clostridium difficile germination is insufficient to prevent colitis: a study in hamsters and humans. Front Microbiol. 2018 Nov;9:2849. https://doi.org/10.3389/fmicb.2018.02849PalmieriLJRainteauDSokolHBeaugerieLDiorMCoffinBHumbertLEguetherTBadoAHoysSInhibitory effect of ursodeoxycholic acid on Clostridium difficile germination is insufficient to prevent colitis: a study in hamsters and humansFront Microbiol2018Nov92849https://doi.org/10.3389/fmicb.2018.0284910.3389/fmicb.2018.02849626207230524414Search in Google Scholar
Ridlon JM, Kang DJ, Hylemon PB. Bile salt biotransformations by human intestinal bacteria. J Lipid Res. 2006 Feb;47(2):241–259. https://doi.org/10.1194/jlr.R500013-JLR200RidlonJMKangDJHylemonPBBile salt biotransformations by human intestinal bacteriaJ Lipid Res2006Feb472241259https://doi.org/10.1194/jlr.R500013-JLR20010.1194/jlr.R500013-JLR20016299351Search in Google Scholar
Seekatz AM, Theriot CM, Rao K, Chang YM, Freeman AE, Kao JY, Young VB. Restoration of short chain fatty acid and bile acid metabolism following fecal microbiota transplantation in patients with recurrent Clostridium difficile infection. Anaerobe. 2018 Feb; 53:64–73. https://doi.org/10.1016/j.anaerobe.2018.04.001SeekatzAMTheriotCMRaoKChangYMFreemanAEKaoJYYoungVBRestoration of short chain fatty acid and bile acid metabolism following fecal microbiota transplantation in patients with recurrent Clostridium difficile infectionAnaerobe2018Feb536473https://doi.org/10.1016/j.anaerobe.2018.04.00110.1016/j.anaerobe.2018.04.001618582829654837Search in Google Scholar
Sehgal K, and Khanna S. Gut microbiome and Clostridioides difficile infection: a closer look at the microscopic interface. Therap Adv Gastroenterol. 2021 Feb;14:1–9. https://doi.org/10.1177/1756284821994736SehgalKKhannaSGut microbiome and Clostridioides difficile infection: a closer look at the microscopic interfaceTherap Adv Gastroenterol2021Feb1419https://doi.org/10.1177/175628482199473610.1177/1756284821994736790571833747125Search in Google Scholar
Sodum N, Kumar G, Bojja SL, Kumar N, Rao CM. Epigenetics in NAFLD/NASH: Targets and therapy. Pharmacol Res. 2021 May; 167:105484. https://doi.org/10.1016/j.phrs.2021.105484SodumNKumarGBojjaSLKumarNRaoCMEpigenetics in NAFLD/NASH: Targets and therapyPharmacol Res2021May167105484https://doi.org/10.1016/j.phrs.2021.10548410.1016/j.phrs.2021.10548433771699Search in Google Scholar
Studer N, Desharnais L, Beutler M, Brugiroux S, Terrazos MA, Menin L, Schürch CM, McCoy KD, Kuehne SA, Minton NP, et al. Functional intestinal bile acid 7α-dehydroxylation by Clostridium scindens associated with protection from Clostridium difficile infection in a gnotobiotic mouse model. Front Cell Infect Microbiol. 2016 Dec;6:191. https://doi.org/10.3389/fcimb.2016.00191StuderNDesharnaisLBeutlerMBrugirouxSTerrazosMAMeninLSchürchCMMcCoyKDKuehneSAMintonNPFunctional intestinal bile acid 7α-dehydroxylation by Clostridium scindens associated with protection from Clostridium difficile infection in a gnotobiotic mouse modelFront Cell Infect Microbiol2016Dec6191https://doi.org/10.3389/fcimb.2016.0019110.3389/fcimb.2016.00191516857928066726Search in Google Scholar
Thanissery R, Winston JA, Theriot CM. Inhibition of spore germination, growth, and toxin activity of clinically relevant C. difficile strains by gut microbiota derived secondary bile acids. Anaerobe. 2017 Jun;45:86–100. https://doi.org/10.1016/j.anaerobe.2017.03.004ThanisseryRWinstonJATheriotCMInhibition of spore germination, growth, and toxin activity of clinically relevant C. difficile strains by gut microbiota derived secondary bile acidsAnaerobe2017Jun4586100https://doi.org/10.1016/j.anaerobe.2017.03.00410.1016/j.anaerobe.2017.03.004546689328279860Search in Google Scholar
Theriot CM, Bowman AA, Young VB. Antibiotic-induced alterations of the gut microbiota alter secondary bile acid production and allow for Clostridium difficile spore germination and outgrowth in the large intestine. MSphere. 2016 Jan;1(1):e00045-15. https://doi.org/10.1128/msphere.00045-15TheriotCMBowmanAAYoungVBAntibiotic-induced alterations of the gut microbiota alter secondary bile acid production and allow for Clostridium difficile spore germination and outgrowth in the large intestineMSphere2016Jan11e00045-15https://doi.org/10.1128/msphere.00045-1510.1128/mSphere.00045-15486361127239562Search in Google Scholar
Theriot CM, Koenigsknecht MJ, Carlson PE, Hatton GE, Nelson AM, Li B, Huffnagle GB, Li JZ, Young VB. Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection. Nat Commun. 2014 Jan;5:3114. https://doi.org/10.1038/ncomms4114TheriotCMKoenigsknechtMJCarlsonPEHattonGENelsonAMLiBHuffnagleGBLiJZYoungVBAntibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infectionNat Commun2014Jan53114https://doi.org/10.1038/ncomms411410.1038/ncomms4114395027524445449Search in Google Scholar
Theriot CM, Koumpouras C, Carlson PE, Bergin II, Aronoff DM, Young VB. Cefoperazone-treated mice as an experimental platform to assess differential virulence of Clostridium difficile strains. Gut Microbes. 2011 Nov–Dec;2(6):326–234. https://doi.org/10.4161/GMIC.19142TheriotCMKoumpourasCCarlsonPEBerginIIAronoffDMYoungVBCefoperazone-treated mice as an experimental platform to assess differential virulence of Clostridium difficile strainsGut Microbes2011Nov–Dec26326234https://doi.org/10.4161/GMIC.1914210.4161/gmic.19142333712122198617Search in Google Scholar
Ticho AL, Malhotra P, Dudeja PK, Gill RK, Alrefai WA. Intestinal absorption of bile acids in health and disease. Compr Physiol. 2019 Dec;10(1):21–56. https://doi.org/10.1002/cphy.c190007TichoALMalhotraPDudejaPKGillRKAlrefaiWAIntestinal absorption of bile acids in health and diseaseCompr Physiol2019Dec1012156https://doi.org/10.1002/cphy.c19000710.1002/cphy.c190007717192531853951Search in Google Scholar
Webb BJ, Brunner A, Lewis J, Ford CD, Lopansri BK. Repurposing an old drug for a new epidemic: ursodeoxycholic acid to prevent recurrent Clostridioides difficile infection. Clin Infect Dis. 2019 Jan;68(3):498–500. https://doi.org/10.1093/cid/ciy568WebbBJBrunnerALewisJFordCDLopansriBKRepurposing an old drug for a new epidemic: ursodeoxycholic acid to prevent recurrent Clostridioides difficile infectionClin Infect Dis2019Jan683498500https://doi.org/10.1093/cid/ciy56810.1093/cid/ciy56830020421Search in Google Scholar
Wei M, Huang F, Zhao L, Zhang Y, Yang W, Wang S, Li M, Han X, Ge K, Qu C, et al. A dysregulated bile acid-gut microbiota axis contributes to obesity susceptibility. EBioMedicine. 2020 May; 55: 102766. https://doi.org/10.1016/j.ebiom.2020.102766WeiMHuangFZhaoLZhangYYangWWangSLiMHanXGeKQuCA dysregulated bile acid-gut microbiota axis contributes to obesity susceptibilityEBioMedicine2020May55102766https://doi.org/10.1016/j.ebiom.2020.10276610.1016/j.ebiom.2020.102766722561432408110Search in Google Scholar
Weingarden AR, Chen C, Zhang N, Graiziger CT, Dosa PI, Steer CJ, Shaughnessy MK, Johnson JR, Sadowsky MJ, Khoruts A. Ursodeoxycholic acid inhibits Clostridium difficile spore germination and vegetative growth, and prevents the recurrence of ileal pouchitis associated with the infection. J Clin Gastroenterol. 2016a Sep;50(8):624–630. https://doi.org/10.1097/MCG.0000000000000427WeingardenARChenCZhangNGraizigerCTDosaPISteerCJShaughnessyMKJohnsonJRSadowskyMJKhorutsAUrsodeoxycholic acid inhibits Clostridium difficile spore germination and vegetative growth, and prevents the recurrence of ileal pouchitis associated with the infectionJ Clin Gastroenterol2016aSep508624630https://doi.org/10.1097/MCG.000000000000042710.1097/MCG.0000000000000427483428526485102Search in Google Scholar
Weingarden AR, Dosa PI, DeWinter E, Steer CJ, Shaughnessy MK, Johnson JR, Khoruts A, Sadowsky MJ. Changes in colonic bile acid composition following fecal microbiota transplantation are sufficient to control Clostridium difficile germination and growth. PLoS One. 2016b Jan;11(1):e0147210. https://doi.org/10.1371/journal.pone.0147210WeingardenARDosaPIDeWinterESteerCJShaughnessyMKJohnsonJRKhorutsASadowskyMJChanges in colonic bile acid composition following fecal microbiota transplantation are sufficient to control Clostridium difficile germination and growthPLoS One2016bJan111e0147210https://doi.org/10.1371/journal.pone.014721010.1371/journal.pone.0147210472048126789728Search in Google Scholar
Wells JE, Hylemon PB. Identification and characterization of a bile acid 7α-dehydroxylation operon in Clostridium sp. strain TO-931, a highly active 7α-dehydroxylating strain isolated from human feces. Appl Environ Microbiol. 2000 Mar;66(3):1107–1113. https://doi.org/10.1128/AEM.66.3.1107-1113.2000WellsJEHylemonPBIdentification and characterization of a bile acid 7α-dehydroxylation operon in Clostridium sp. strain TO-931, a highly active 7α-dehydroxylating strain isolated from human fecesAppl Environ Microbiol2000Mar66311071113https://doi.org/10.1128/AEM.66.3.1107-1113.200010.1128/AEM.66.3.1107-1113.20009194910698778Search in Google Scholar
Winston JA, Rivera AJ, Cai J, Thanissery R, Montgomery SA, Patterson AD, Theriot CM. Ursodeoxycholic acid (UDCA) mitigates the host inflammatory response during Clostridioides difficile infection by altering gut bile acids. Infect Immun. 2020 May; 88(6): e00045-20. https://doi.org/10.1128/IAI.00045-20WinstonJARiveraAJCaiJThanisseryRMontgomerySAPattersonADTheriotCMUrsodeoxycholic acid (UDCA) mitigates the host inflammatory response during Clostridioides difficile infection by altering gut bile acidsInfect Immun2020May886e00045-20https://doi.org/10.1128/IAI.00045-2010.1128/IAI.00045-20724009532205405Search in Google Scholar
Winston JA, Theriot CM. Diversification of host bile acids by members of the gut microbiota. Gut Microbes. 2020 Oct;11(2):158–171. https://doi.org/10.1080/19490976.2019.1674124WinstonJATheriotCMDiversification of host bile acids by members of the gut microbiotaGut Microbes2020Oct112158171https://doi.org/10.1080/19490976.2019.167412410.1080/19490976.2019.1674124705388331595814Search in Google Scholar
Winston JA, Theriot CM. Impact of microbial derived secondary bile acids on colonization resistance against Clostridium difficile in the gastrointestinal tract. Anaerobe. 2016 Oct;41:44–50. https://doi.org/10.1016/j.anaerobe.2016.05.003WinstonJATheriotCMImpact of microbial derived secondary bile acids on colonization resistance against Clostridium difficile in the gastrointestinal tractAnaerobe2016Oct414450https://doi.org/10.1016/j.anaerobe.2016.05.00310.1016/j.anaerobe.2016.05.003505008327163871Search in Google Scholar
Xie C, Huang W, Young RL, Jones KL, Horowitz M, Rayner CK, Wu T. Role of bile acids in the regulation of food intake, and their dysregulation in metabolic disease. Nutrients. 2021 Mar;13(4):1104. https://doi.org/10.3390/nu13041104XieCHuangWYoungRLJonesKLHorowitzMRaynerCKWuTRole of bile acids in the regulation of food intake, and their dysregulation in metabolic diseaseNutrients2021Mar1341104https://doi.org/10.3390/nu1304110410.3390/nu13041104806618233800566Search in Google Scholar
Zhang Y, LaCerte C, Kansra S, Jackson JP, Brouwer KR, Edwards JE. Comparative potency of obeticholic acid and natural bile acids on FXR in hepatic and intestinal in vitro cell models. Pharmacol Res Perspect. 2017 Dec;5(6):e00368. https://doi.org/10.1002/prp2.368ZhangYLaCerteCKansraSJacksonJPBrouwerKREdwardsJEComparative potency of obeticholic acid and natural bile acids on FXR in hepatic and intestinal in vitro cell modelsPharmacol Res Perspect2017Dec56e00368https://doi.org/10.1002/prp2.36810.1002/prp2.368572370129226620Search in Google Scholar